about
Detection of microorganisms in granulomas that have been formalin-fixed: review of the literature regarding use of molecular methodsDirect comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasisInterleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.Insulin-like growth factor-I induces arginase activity in Leishmania amazonensis amastigote-infected macrophages through a cytokine-independent mechanism.Cell death and ultrastructural alterations in Leishmania amazonensis caused by new compound 4-Nitrobenzaldehyde thiosemicarbazone derived from S-limonene.Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning TravelersAblative fractional laser resurfacing with topical paromomycin as adjunctive treatment for a recalcitrant cutaneous leishmaniasis wound.Insulin-like growth factor-I serum levels and their biological effects on Leishmania isolates from different clinical forms of American tegumentary leishmaniasis.Pharmacotherapy for leishmaniasis in the United States: focus on miltefosine.Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.American cutaneous leishmaniasis: In situ immune response of patients with recent and late lesions.A3K2A3-induced apoptotic cell death of Leishmania amazonensis occurs through caspase- and ATP-dependent mitochondrial dysfunction.Detection and identification of Leishmania spp.: application of two hsp70-based PCR-RFLP protocols to clinical samples from the New World.Molecular and histological tools to diagnose an imported case of American cutaneous leishmaniasis in Cuba.Murine cutaneous leishmaniasis investigated by MALDI mass spectrometry imaging.Detection and molecular identification of leishmania RNA virus (LRV) in Iranian Leishmania species.Fast, sensitive and specific diagnosis of infections with Leishmania spp. in formalin-fixed, paraffin-embedded skin biopsies by cytochrome b polymerase chain reaction.GENOTYPE CHARACTERIZATION OF Leishmania (Viannia) braziliensis ISOLATED FROM HUMAN AND CANINE BIOPSIES WITH AMERICAN CUTANEOUS LEISHMANIASIS.Differential identification of Sporothrix spp. and Leishmania spp. by conventional PCR and qPCR in multiplex format.Analytical Performance of Four Polymerase Chain Reaction (PCR) and Real Time PCR (qPCR) Assays for the Detection of Six Leishmania Species DNA in Colombia.Dipeptidyl peptidase 3, a novel protease from Leishmania braziliensis.
P2860
Q27023619-05322781-B386-4929-A4FD-C2DE29A33360Q28542936-A3FF9574-AB27-4502-B451-39B0F729E05EQ33633481-CC06A0AE-BF7C-4EC5-AD43-D4615A7238BDQ33909932-4F253CCE-774F-4C3D-99B1-30C26C34BDCDQ34247302-D2FCA02F-FE11-40AA-BA57-21957902C995Q34301130-7358BD3B-FAF7-4E00-8C2F-43B1D6FDA442Q35180338-5C5CC350-4C59-423A-870C-6D1D66F8D67DQ35792230-2593AA0C-00CE-42D7-B2FF-B837961A7CFBQ36994550-465F9B18-DDA5-4A65-B167-76E550484C89Q38458645-ECE4CF95-ABE1-4C13-A57E-E0E27208D326Q38934573-85DF62F0-E1FB-4C3C-A442-F5F96CBA4EF6Q38940537-DA99FE3F-9CEE-4763-80F4-254AB6859132Q39017135-22DE2415-011F-4C57-97ED-853E6932D857Q39263491-50DEF6C0-E4B6-4F12-921E-908A773F4279Q39263503-34F709E6-7FEB-4D12-9835-37621DD8289AQ39298243-9597C267-65A1-400C-ACC5-62BF5DCCB7A6Q39413677-1E59B182-2090-4578-BA47-58AFB685CBE9Q40629610-07D2B669-0E58-4B25-9920-F5DEC93A0597Q40708388-428FAA84-7F63-488B-9FB3-F3D5DCDE6A77Q41589901-FC0B102D-3D48-41DC-8FFD-6B132D4867A7Q42372936-B4E21E77-DA51-409B-A3C7-2BE456DE712DQ47229887-C5541DC4-41CF-4C06-9FE8-84502450ED49
P2860
description
im April 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 17 April 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2012
@uk
name
Cutaneous and Mucocutaneous Leishmaniasis
@en
Cutaneous and Mucocutaneous Leishmaniasis
@nl
type
label
Cutaneous and Mucocutaneous Leishmaniasis
@en
Cutaneous and Mucocutaneous Leishmaniasis
@nl
prefLabel
Cutaneous and Mucocutaneous Leishmaniasis
@en
Cutaneous and Mucocutaneous Leishmaniasis
@nl
P1476
Cutaneous and mucocutaneous leishmaniasis
@en
P2093
José Angelo Lauletta Lindoso
P304
P356
10.1016/J.IDC.2012.03.001
P50
P577
2012-04-17T00:00:00Z